BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

SUCAMPO PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · Registration - Amendment

SUCAMPO PHARMACEUTICALS

via WILMER CUTLER PICKERING HALE AND DORR LLP

1st Quarter (Jan 1 - Mar 31) · 2017Posted Aug 7, 2017Filing document ↗LDA record ↗

Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.

Client

Name: SUCAMPO PHARMACEUTICALS
Description: Pharmaceutical
Location: Maryland · United States of America

Registrant

Firm: WILMER CUTLER PICKERING HALE AND DORR LLP
Description: law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Issues relating to orphan drugs
LobbyistsKIRSTEN DONALDSON · TIMOTHY MARTIN · mr JONATHAN RAPHAEL YAROWSKY
Covered position (KIRSTEN DONALDSON): LD/GC Rep. Jeffries (13-16); Leg. Fellow House Jud. Com. (09-10)
Covered position (TIMOTHY MARTIN): GC/Senior LA Rep. Tipton (14-15); LD Rep. Davis (15-17)
Covered position (mr JONATHAN RAPHAEL YAROWSKY): GCHouse Jud. Com. 82-95; SAC Pres 95-98

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.